Article Listing - BioAlliance Pharma’s Lauriad brings benefits in Ph III

SEARLE CANADA - RICHARD HINSON

11 May 1992

Richard Hinson has been appointed as president and general manager of Searle Canada Inc, following the departure of Robert Whitehead,...

REPLIGEN - ALAN JARVIS

11 May 1992

Repligen has announced the appointment of Allan Jarvis to the new position of vice president, business planning, which includes responsibility...

CYANAMID ITALIA - CLAUDIO PISANI

11 May 1992

Claudio Pisani has been appointed managing director of Cyanamid Italia.

XENOVA - HENRI TERMEER

11 May 1992

Genzyme Corp president, chief executive and chairman Henri Termeer has been appointed to the board of the UK biotechnology company...

STOCK MARKET COMMENTARY: EUROPE

11 May 1992

EUROPE: saw the major markets of Zurich, Paris and London on an upbeat note, but FRANKFURT was down, influenced by...

STOCK MARKET COMMENTARY: NEW YORK

11 May 1992

NEW YORK: equities moved up steadily ahead of the weekend, but a round of sell programs on Friday, coupled with...

QLT STARTS 2nd GEN CANCER DRUG TRIALS

11 May 1992

As Canada's Quadra Logic Technologies heads towards marketing its first anticancer compound, the Canadian government has given the go-ahead for...

UK MRC REVERSES AIDS VACCINE STANCE

11 May 1992

The UK Medical Research Council has decided to back an alternative AIDS vaccine project put forward by the Human Immunodeficiency...

UK APPROVAL OF ORAL IMIGRAN

11 May 1992

Glaxo Holdings has announced that its UK subsidiary has been granted a license to market the oral formulation of its...

HOECHST'S TARIVID FOR NF PATIENTS

11 May 1992

Results of a study conducted with Hoechst's broad-spectrum fluoroquinolone antibiotic Tarivid (ofloxacin) suggest that when used as a single agent...

Showing 94181-94190 of 95558 articles

Go to beginningPreviousNextGo to end